Ipratropium Bromide And Albuterol Sulfate Solution
Product Images NDC 69097-840

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Ipratropium Bromide And Albuterol Sulfate (NDC 69097-840). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

641c0abd 3bb1 4ad8 B132 D90f8533adf8 01

Chemical structure diagram depicting the molecular formula of Ipratropium Bromide complexed with sulfuric acid (H2SO4). The illustration shows its chemical bonds and molecular composition related to the active ingredient Ipratropium Bromide in the inhalation solution.*

FDA Label Image

641c0abd 3bb1 4ad8 B132 D90f8533adf8 02

Chemical structure of Ipratropium Bromide, depicting its molecular composition with labeled atoms and bonds, including the bromide ion and water of hydration.*

FDA Label Image

641c0abd 3bb1 4ad8 B132 D90f8533adf8 03

A line graph showing the volume in liters over hours after dosing for three substances: Albuterol, Ipratropium, and their combination Ipratropium Bromide and Albuterol Sulfate. The graph plots lung function changes over an 8-hour period following inhalation dosing.*

FDA Label Image

641c0abd 3bb1 4ad8 B132 D90f8533adf8 04

An instructional diagram showing a hand holding a dropper bottle dispensing liquid into a small inhaler device with a mouthpiece, illustrating how to prepare the respiratory inhalation solution for administration.*

FDA Label Image

641c0abd 3bb1 4ad8 B132 D90f8533adf8 05

An instructional diagram showing the assembly or preparation of a respiratory inhalation device, with a close-up insertion of a component into the inhaler mechanism. The image illustrates handling and connection steps related to the inhalation device's use.*

FDA Label Image

641c0abd 3bb1 4ad8 B132 D90f8533adf8 06

Instructional illustrations showing a person using a respiratory inhalation solution device. Figure 3 depicts the person inhaling through the mouthpiece, and Figure 4 shows the person with a holding chamber or spacer attached to the inhaler for administration. These images demonstrate proper technique for using the inhalation device.*

FDA Label Image

641c0abd 3bb1 4ad8 B132 D90f8533adf8 07

Packaging label for Ipratropium Bromide and Albuterol Sulfate inhalation solution, 0.5 mg/2.5 mg per 3 mL, for oral inhalation use only. The label shows the product name, dosage strength, route of administration, and labeler Cipla USA Inc. It includes NDC 69097-840, barcodes, and regulatory information on a folded carton template.*

FDA Label Image

641c0abd 3bb1 4ad8 B132 D90f8533adf8 08

Packaging label for Ipratropium Bromide and Albuterol Sulfate solution, 0.5 mg/3 mL and 2.5 mg/3 mL strengths, for respiratory inhalation use. The label indicates the product is manufactured by Cipla USA Inc. and intended for prescription use only. The carton design includes dosage information, route of administration, and usage instructions for oral inhalation only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.